Company Advaxis, Inc. Nasdaq
Equities
US0076242082
Biotechnology & Medical Research
Business Summary
Managers
Managers | Title | Age | Since |
---|---|---|---|
Ken Berlin
CEO | Chief Executive Officer | 59 | 18-04-22 |
- | - | ||
- | - | ||
- | - | ||
- | - |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
David Sidransky
CHM | Chairman | 64 | 13-07-15 |
Roni Appel
CEO | Chief Executive Officer | 57 | 04-10-31 |
Murray Goldberg
BRD | Director/Board Member | 79 | 23-01-18 |
Robert Spiegel
BRD | Director/Board Member | 73 | 23-01-18 |
- | - | ||
Ken Berlin
CEO | Chief Executive Officer | 59 | 18-04-22 |
Director/Board Member | 53 | 23-01-18 | |
44 | - |
Company contact information
Sector
1st Jan change | Capi. | |
---|---|---|
+16.59% | 44.44B | |
+41.02% | 39.84B | |
-10.62% | 37.68B | |
+29.92% | 31.46B | |
-9.23% | 27.02B | |
+12.34% | 26.29B | |
+41.53% | 13.8B | |
+31.49% | 12.46B | |
-7.40% | 11.26B |